It could reduce both breast cancer and squamous cell carcinoma invasion and displayed relatively good potency with affinity concentrations (Ki) of 10 nM and 4 nM for MRCKα and MRCKβ, respectively. This evidence concerns the gene CDC42BPA and breast cancer.